News
Stockhead on MSN14m
Dimerix inks lucrative US licensing deal for phase III drug candidateDimerix has entered an exclusive licensing deal with Amicus Therapeutics to commercialise its phase III drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback